Key facts
- Becky Jones was diagnosed with a terminal brain tumor at 21 and told she had months to live.
- She underwent 11 years of chemotherapy treatment.
- Jones has learned she never had cancer but an inflammation of the brain.
- She is among more than 40 patients taking legal action against University Hospitals Coventry and Warwickshire (UHCW) NHS Trust.
- A review of cases connected to consultant Prof Ian Brown found 15 out of 20 reviewed were unsatisfactory.
- The trust stated that all affected patients have been reviewed by senior clinicians.
Becky Jones, now 33, was diagnosed with a terminal brain tumor at age 21 and subsequently underwent 11 years of chemotherapy. She has recently discovered that she never had cancer but instead suffered from an inflammation of the brain that could have been treated with steroids.
Jones is one of more than 40 patients initiating legal action against the University Hospitals Coventry and Warwickshire (UHCW) NHS Trust for prolonged or unnecessary cancer treatment. She stated that she was repeatedly told that without chemotherapy, she would die. Consultant Prof Ian Brown at University Hospital, Coventry, reportedly advised her to take the chemotherapy drug temozolomide (TMZ) for the rest of her life, despite guidelines suggesting a six-month course. Jones questioned the lack of visible tumors in scans, but was told they would not be "visible to the naked eye."
The truth emerged in 2025 during a review of cancer cases at the trust linked to Prof Brown. Jones expressed her devastation, stating, "He's just ruined my life, essentially." Many other patients of Prof Brown have reported receiving TMZ for years, leading to serious medical issues. A review found staff failings amounted to a "betrayal of patient trust" and questioned why oncology pharmacy teams did not challenge prolonged chemotherapy prescriptions.
UHCW has stated it is not commenting on individual cases but has implemented measures for "more robust oversight of the prescription and use of TMZ." The trust is also conducting an independent review of its speak-up processes. A preliminary review of 20 cases related to "Dr Y" (believed to be Prof Brown) found 15 "unsatisfactory overall," citing "insufficient clinical curiosity" and a lack of multidisciplinary team collaboration.